Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Present And Forecasted Size Of The Yellow Fever Vaccine Market?

Over the past few years, the market size for the yellow fever vaccine has shown consistent growth. The market is expected to expand from $4.54 billion in 2024 to $4.74 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. This growth during the historic period is credited to the launch of worldwide immunization initiatives, enactment of international health laws, large-scale vaccination drives, and progress in vaccine production technology.

Anticipations are set for a consistent expansion of the yellow fever vaccine market in the coming years. The market is projected to swell up to “$5.66 billion by the year 2029, achieving a compound annual growth rate (CAGR) of 4.5%. Factors contributing to this growth during the projection period include enhanced collaborations and partnerships, incorporation in standard immunization timelines, advanced surveillance and vigilance, rising participation of private sectors, and the embracement of digital innovation for vaccine monitoring. Prominent trends for this period count on the diversification of vaccine molds, preparedness for pandemics, modifications in regulations, advancements in healthcare infrastructure, and initiatives towards consumer education and consciousness.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

What Core Drivers Are Expected To Influence The Yellow Fever Vaccine Market?

The surge in global travel is predicted to drive the expansion of the yellow fever vaccine market. Global travel entails the cross-border movement of people for reasons such as tourism, work, or personal matters. An upswing in global connectivity, economic advancement, and the easing of travel restrictions in the post-pandemic era are fueling the rise in international travel. The yellow fever vaccine is either mandatory or advised for individuals traveling to areas where yellow fever is prevalent to prevent contraction of the disease and adhere to global health rules. For example, data from the World Tourism Organization, a Spanish agency, shows that in 2023, there were 1.286 billion global tourists (those staying overnight), compared to 960 million in 2022. This represents a boost of 326 million international tourists between 2022 and 2023. Consequently, the increased volume of international travel is stimulating the expansion of the yellow fever vaccine market.

What Segmentation Insights Are Provided In The Yellow Fever Vaccine Market Research?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Treatment Type: Pain Management Drugs, Oral Rehydration

3) By Application: Routine Immunization, Travelers, Other Applications

4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Which Notable Trends Are Transforming The Yellow Fever Vaccine Market Outlook?

Key players in the yellow fever vaccine market are channeling their efforts towards the development of efficient next-generation vaccines for yellow fever, like the T-cell adaptive booster vaccine, in response to the rising worldwide demand for vaccines. These booster vaccines are designed to amplify the immune system’s recollection of T-cells, thereby offering extended and strong immunity to certain pathogens. To cite an example, in April 2022, Emergex Vaccines Holding Limited, a biotechnology firm based in the UK, collaborated with the US-based non-profit organization, ATCC, which offers reference microorganisms, cell lines, and other materials for research and development. Together, they are developing CD8+ T-cell adaptive vaccines for yellow fever. The goal is to trigger a strong cytotoxic T-cell response, necessary for the detection and destruction of virus-infected cells. By encouraging the generation of memory CD8+ T-cells, these vaccines offer enduring and robust immunity. Instead of limiting their focus to antibody production, these vaccines aim at engaging the cellular immune response, promising comprehensive protection against yellow fever and potentially boosting effectiveness among individuals with varying immunity profiles.

Which Companies Are Contributing Significantly To The Yellow Fever Vaccine Market Growth?

Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Yellow Fever Vaccine Market?

North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model